Pharmaxis Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other
companies in this sector in Australia:
sales of 37.49 million Australian Dollars [US$26.74 million]
of which 97%
was Clinical Trials),
Xrf Scientific Ltd
(24.25 million Australian Dollars [US$17.30 million]
of which 42%
was Precious Metals), and
Clinuvel Pharmaceuticals Limited
(25.75 million Australian Dollars [US$18.37 million]
of which 100%
Sales increased substantially in 2018:
During the year ended June of 2018, sales at
Pharmaxis Ltd were A$50.33 million (US$35.90 million).
increase of 185.4%
versus 2017, when the company's sales were A$17.64 million.